Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy. The company is developing therapies that target cancer cells that have co-opted immune signaling pathways to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
Funding
Employees
Discover the best career opportunities with the best company cultures for you.
Connect your business to thousands of engaged professionals in your city and beyond.